AU4281200A - Immuno-adjuvant pdt treatment of metastatic tumors - Google Patents

Immuno-adjuvant pdt treatment of metastatic tumors

Info

Publication number
AU4281200A
AU4281200A AU42812/00A AU4281200A AU4281200A AU 4281200 A AU4281200 A AU 4281200A AU 42812/00 A AU42812/00 A AU 42812/00A AU 4281200 A AU4281200 A AU 4281200A AU 4281200 A AU4281200 A AU 4281200A
Authority
AU
Australia
Prior art keywords
immuno
metastatic tumors
pdt treatment
adjuvant
adjuvant pdt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42812/00A
Inventor
P. Mark Curry
David W. C. Hunt
Julia G. Levy
Anna M. Richter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Novelion Therapeutics Inc
Original Assignee
University of British Columbia
QLT Inc
Quadra Logic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia, QLT Inc, Quadra Logic Technologies Inc filed Critical University of British Columbia
Publication of AU4281200A publication Critical patent/AU4281200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
AU42812/00A 1999-04-23 2000-04-20 Immuno-adjuvant pdt treatment of metastatic tumors Abandoned AU4281200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13051999P 1999-04-23 1999-04-23
US60130519 1999-04-23
PCT/CA2000/000480 WO2000064476A2 (en) 1999-04-23 2000-04-20 Immuno-adjuvant pdt treatment of metastatic tumors

Publications (1)

Publication Number Publication Date
AU4281200A true AU4281200A (en) 2000-11-10

Family

ID=22445059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42812/00A Abandoned AU4281200A (en) 1999-04-23 2000-04-20 Immuno-adjuvant pdt treatment of metastatic tumors

Country Status (4)

Country Link
EP (1) EP1173203A2 (en)
AU (1) AU4281200A (en)
CA (1) CA2369542C (en)
WO (1) WO2000064476A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2439811A1 (en) * 2001-03-05 2002-09-12 Lymphotec Inc. Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
EP1443964B1 (en) * 2001-11-09 2008-02-20 QLT Inc. Photodynamic therapy for the treatment of hair loss
GB201120779D0 (en) 2011-12-02 2012-01-11 Immodulon Therapeutics Ltd Cancer therapy
GB201308325D0 (en) 2013-05-09 2013-06-19 Immodulon Therapeutics Ltd Cancer Therapy
GB201322725D0 (en) 2013-12-20 2014-02-05 Immodulon Therapeutics Ltd Cancer therapy
CN114344462A (en) 2015-06-24 2022-04-15 英摩杜伦治疗学公司 Checkpoint inhibitors and whole cell mycobacteria for cancer therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316007B1 (en) * 1995-04-04 2001-11-13 Wound Healing Of Oklahoma Combined physical and immunotherapy for cancer
WO1996031237A2 (en) * 1995-04-04 1996-10-10 Wound Healing Of Oklahoma Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant

Also Published As

Publication number Publication date
CA2369542C (en) 2009-10-27
WO2000064476A2 (en) 2000-11-02
CA2369542A1 (en) 2000-11-02
EP1173203A2 (en) 2002-01-23
WO2000064476A3 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
AU5089799A (en) Drug complex for treatment of metastatic prostate cancer
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
EP1175616A4 (en) Methods for the diagnosis and treatment of metastatic prostate tumors
AU2991299A (en) Monoterpenoid derivatives for treatment of cancer
AU4369800A (en) Treatment of metastatic cancer through mts-1 gene
AU2002221521A1 (en) Immunotherapeutic combinations for the treatment of tumors
AU4281200A (en) Immuno-adjuvant pdt treatment of metastatic tumors
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU6617498A (en) Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU1595101A (en) Oncolytic combinations for the treatment of cancer
GB9819999D0 (en) Treatment of cancer
AU4452900A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2390700A (en) Polypeptidic compositions and methods for the treatment of tumors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase